Rankings
▼
Calendar
ACET FY 2019 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena
ACET
Adicet Bio, Inc.
$71M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$995,000
-87.8% YoY
Gross Profit
$995,000
100.0% margin
Operating Income
-$31M
-3154.6% margin
Net Income
-$28M
-2827.9% margin
EPS (Diluted)
$-24.32
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$29M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$82M
Total Liabilities
$142M
Stockholders' Equity
-$60M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$995,000
$8M
-87.8%
Gross Profit
$995,000
$8M
-87.7%
Operating Income
-$31M
-$15M
-109.8%
Net Income
-$28M
-$9M
-202.6%
← Q4 2018
All Quarters
Q1 2019 →